In vitro immune modulation by antibodies coupled to tumour cells.
Modification of autologous tumour cells to express the immune costimulator B7.1 is a potential strategy for immunotherapy of cancer. Previously, this has involved introduction of genetic material into cells, in vitro culture, and confirmation of the protein product on the cell surface. This is possi...
| मुख्य लेखकों: | , , , , , , , , , , |
|---|---|
| स्वरूप: | Journal article |
| भाषा: | English |
| प्रकाशित: |
1997
|
| _version_ | 1826305818114392064 |
|---|---|
| author | Darling, D Galea-Lauri, J Gäken, J Towner, P Kuiper, M Hollingsworth, S Hirst, W Barnard, A Buggins, A Mufti, G Farzaneh, F |
| author_facet | Darling, D Galea-Lauri, J Gäken, J Towner, P Kuiper, M Hollingsworth, S Hirst, W Barnard, A Buggins, A Mufti, G Farzaneh, F |
| author_sort | Darling, D |
| collection | OXFORD |
| description | Modification of autologous tumour cells to express the immune costimulator B7.1 is a potential strategy for immunotherapy of cancer. Previously, this has involved introduction of genetic material into cells, in vitro culture, and confirmation of the protein product on the cell surface. This is possible only if sufficient tumour is obtainable and efficiently modified in a short time. Whilst progress has been made on ex vivo tumour cell culture and transfection/infection procedures there are still tumour types for which the present means of gene transfer are not efficient enough. We describe a highly efficient in vitro procedure for the modification of over 99% of the cells in a population, allowing the expression of cell surface proteins with potential immune modulatory activities. This procedure, which can be completed in as little as 24 h with no upper limit on cell number, utilizes succinimide esters to label cell surface proteins with biotin covalently. Biotinylated cell membrane proteins then anchor an avidin bridge for immobilizing protein G'-biotin. This can serve to bind immunoglobulin (Ig) molecules via their Fc region such that the variable region of the antibody is freely and functionally available. In the present study the binding of a stimulatory mouse anti-human CD28 monoclonal antibody to the surface of tumour cells is used to show that the modified cells are capable of co-stimulating T cells in vitro. The simplicity of the method, and the use of common reagents, represents a further step towards a realistic, truly 'off-the-shelf', nongene immunotherapy protocol. |
| first_indexed | 2024-03-07T06:38:37Z |
| format | Journal article |
| id | oxford-uuid:f8839c0f-4bb1-45da-a94c-cb030ce2b74a |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T06:38:37Z |
| publishDate | 1997 |
| record_format | dspace |
| spelling | oxford-uuid:f8839c0f-4bb1-45da-a94c-cb030ce2b74a2022-03-27T12:50:46ZIn vitro immune modulation by antibodies coupled to tumour cells.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:f8839c0f-4bb1-45da-a94c-cb030ce2b74aEnglishSymplectic Elements at Oxford1997Darling, DGalea-Lauri, JGäken, JTowner, PKuiper, MHollingsworth, SHirst, WBarnard, ABuggins, AMufti, GFarzaneh, FModification of autologous tumour cells to express the immune costimulator B7.1 is a potential strategy for immunotherapy of cancer. Previously, this has involved introduction of genetic material into cells, in vitro culture, and confirmation of the protein product on the cell surface. This is possible only if sufficient tumour is obtainable and efficiently modified in a short time. Whilst progress has been made on ex vivo tumour cell culture and transfection/infection procedures there are still tumour types for which the present means of gene transfer are not efficient enough. We describe a highly efficient in vitro procedure for the modification of over 99% of the cells in a population, allowing the expression of cell surface proteins with potential immune modulatory activities. This procedure, which can be completed in as little as 24 h with no upper limit on cell number, utilizes succinimide esters to label cell surface proteins with biotin covalently. Biotinylated cell membrane proteins then anchor an avidin bridge for immobilizing protein G'-biotin. This can serve to bind immunoglobulin (Ig) molecules via their Fc region such that the variable region of the antibody is freely and functionally available. In the present study the binding of a stimulatory mouse anti-human CD28 monoclonal antibody to the surface of tumour cells is used to show that the modified cells are capable of co-stimulating T cells in vitro. The simplicity of the method, and the use of common reagents, represents a further step towards a realistic, truly 'off-the-shelf', nongene immunotherapy protocol. |
| spellingShingle | Darling, D Galea-Lauri, J Gäken, J Towner, P Kuiper, M Hollingsworth, S Hirst, W Barnard, A Buggins, A Mufti, G Farzaneh, F In vitro immune modulation by antibodies coupled to tumour cells. |
| title | In vitro immune modulation by antibodies coupled to tumour cells. |
| title_full | In vitro immune modulation by antibodies coupled to tumour cells. |
| title_fullStr | In vitro immune modulation by antibodies coupled to tumour cells. |
| title_full_unstemmed | In vitro immune modulation by antibodies coupled to tumour cells. |
| title_short | In vitro immune modulation by antibodies coupled to tumour cells. |
| title_sort | in vitro immune modulation by antibodies coupled to tumour cells |
| work_keys_str_mv | AT darlingd invitroimmunemodulationbyantibodiescoupledtotumourcells AT galealaurij invitroimmunemodulationbyantibodiescoupledtotumourcells AT gakenj invitroimmunemodulationbyantibodiescoupledtotumourcells AT townerp invitroimmunemodulationbyantibodiescoupledtotumourcells AT kuiperm invitroimmunemodulationbyantibodiescoupledtotumourcells AT hollingsworths invitroimmunemodulationbyantibodiescoupledtotumourcells AT hirstw invitroimmunemodulationbyantibodiescoupledtotumourcells AT barnarda invitroimmunemodulationbyantibodiescoupledtotumourcells AT bugginsa invitroimmunemodulationbyantibodiescoupledtotumourcells AT muftig invitroimmunemodulationbyantibodiescoupledtotumourcells AT farzanehf invitroimmunemodulationbyantibodiescoupledtotumourcells |